Category: Drug Development
Drug Development market research reports by Icon Group International, Inc.
-
The 2026-2031 World Outlook for Oncolytic Virus Immunotherapies
This study covers the world outlook for oncolytic virus immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ... Read More
-
The 2026-2031 World Outlook for Mutation-Suppression Duchenne Muscular Dystrophy Drugs
This study covers the world outlook for mutation-suppression Duchenne muscular dystrophy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the pe ... Read More
-
The 2026-2031 World Outlook for Oncology Small Molecule Drug Discovery
This study covers the world outlook for oncology small molecule drug discovery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the ... Read More
-
The 2026-2031 World Outlook for Neuroendocrine Tumors
This study covers the world outlook for neuroendocrine tumors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the ... Read More
-
The 2026-2031 World Outlook for Organ-on-a-Chip
This study covers the world outlook for organ-on-a-chip across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the regio ... Read More
-
The 2026-2031 World Outlook for Oral Thin Film Drug Manufacturing
This study covers the world outlook for oral thin film drug manufacturing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the count ... Read More
-
The 2026-2031 World Outlook for Natural Killer Cell Therapeutics
This study covers the world outlook for natural killer cell therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the countr ... Read More
-
The 2026-2031 World Outlook for Cancer-Treating Drugs
This study covers the world outlook for cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the ... Read More
-
The 2026-2031 World Outlook for Breakthrough Therapy Designation
This study covers the world outlook for breakthrough therapy designation across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the countr ... Read More
-
The 2026-2031 World Outlook for RNA Therapeutics
This study covers the world outlook for RNA therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the regi ... Read More
-
The 2026-2031 World Outlook for RNA-Based Therapeutics
This study covers the world outlook for RNA-based therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of th ... Read More
-
The 2026-2031 World Outlook for Drug Discovery Services
This study covers the world outlook for drug discovery services across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of t ... Read More
-
The 2026-2031 World Outlook for Drug Discovery and Development RNA Interference (RNAi)
This study covers the world outlook for drug discovery and development RNA interference (RNAi) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the pe ... Read More
-
The 2026-2031 World Outlook for Immune Checkpoint Inhibitors
This study covers the world outlook for immune checkpoint inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is ... Read More
-
The 2026-2031 World Outlook for Metabolomics Technologies
This study covers the world outlook for metabolomics technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ... Read More
-
The 2026-2031 World Outlook for Biosimulations
This study covers the world outlook for biosimulations across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region ... Read More
-
The 2026-2031 World Outlook for Cloud-Based Drug Discovery Platforms
This study covers the world outlook for cloud-based drug discovery platforms across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the co ... Read More
-
The 2026-2031 World Outlook for Antiviral Drugs
This study covers the world outlook for antiviral drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the regio ... Read More
-
The 2026-2031 World Outlook for Fragment Screening Drug Discovery
This study covers the world outlook for fragment screening drug discovery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the count ... Read More
-
The 2026-2031 World Outlook for High Content Screening-Imaging
This study covers the world outlook for high content screening-imaging across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ... Read More
-
The 2026-2031 World Outlook for Drug Discovery Outsourcing
This study covers the world outlook for drug discovery outsourcing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is o ... Read More
-
The 2026-2031 World Outlook for Immunotherapy Drugs
This study covers the world outlook for immunotherapy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the r ... Read More
-
The 2026-2031 World Outlook for Immunotherapy Cancer Drugs
This study covers the world outlook for immunotherapy cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is o ... Read More
-
The 2026-2031 World Outlook for Glioblastoma Multiforme Drugs
This study covers the world outlook for glioblastoma multiforme drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country i ... Read More
-
The 2026-2031 World Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs
This study covers the world outlook for anti-viral nucleotide polymerase inhibitor drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent ... Read More
Research Assistance
